Print Page  |  Close Window

Investor Overview

NASDAQ: XBIT0.064.19Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
DateTitle 
11/14/17XBiotech Announces Presentation of Novel Findings for MABp1 in the Prevention of Coronary Thrombosis at the American Heart Association Scientific SessionsPrinter Friendly Version
11/03/17XBiotech’s MABp1 to be Featured in Oral Presentation at the American Heart Association Scientific SessionsPrinter Friendly Version
10/18/17XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with OnivydeⓇ and 5-fluorouracil/folinic acid for the Treatment of Pancreatic CancerPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »